Fresh analysis suggests that people who stop using new slimming jabs like Mounjaro or Wegovy can put back on shed pounds far faster than those who halt traditional diet and exercise plans.
Research printed in a major health publication demonstrates that while overweight individuals can lose substantial amounts of their total mass while using the jabs, the weight returns at an average rate of 0.8 kg per month once they quit.
"Individuals buying these treatments should be informed of the risk of quick rebound weight gain when the therapy ends," warns expert Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment mass within about a year and a half.
Analyzing Therapies
The analysis, which looked at dozens of studies involving thousands of patients, compared the effects of the injectable medications with other pills.
Researchers emphasize that individuals who lose weight through lifestyle changes alone generally see a more gradual weight regain—perhaps 0.1 kg a month—after stopping.
Understanding the Fast Regain
Nutrition scientists believe the mode of action of the jabs is key to understanding the accelerated weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Artificially providing the hormone concentrations far above than the body's typical production could lead to the body to produce less of its endogenous GLP-1, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making overeating much more probable."
An Ongoing Disease?
Medical guidelines suggest the injections for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
A number of clinicians say that, given the likelihood of weight regain, the treatment should be considered ongoing.
This view is reinforced by pharmaceutical companies, who say that the findings "emphasize the long-term character of obesity," comparing it to managing diseases like diabetes.
Patient Accounts
Users who have discontinued the jabs explain a intense resurgence of appetite.
"It was like something activating and you become ravenous," said one woman.
This difficulty is compounded if users have not adopted lasting lifestyle or habit modifications during treatment.
Significant Interest
Figures show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with interest continuing to grow.
- Adoption is more common among women compared to males.
- The middle-aged age group shows the greatest usage rates.
- Many access the medications through private prescriptions rather than public health services.
Finally, experts caution that while the jabs are powerful agents for shedding pounds, they are not a magic solution and long-term success hinges on integrated lifestyle support.
